Literature DB >> 16944213

Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.

D Maroeska Te Loo1, Leo Monnens, Thea van der Velden, Mohammed Karmali, Lambertus van den Heuvel, Victor van Hinsbergh.   

Abstract

Acute renal failure hallmarks the pathogenesis of the epidemic form of hemolytic uremic syndrome (D+HUS), which is caused by E. coli strains that produce Shiga-like toxin (Stx). In this study, we investigated the influence of Stx-1 on nitric oxide (NO) production by human glomerular microvascular endothelial cells (GMVEC) and human mesangial cells. NO synthesis by human mesangial cells is in the micromolar range and that of GMVEC in the picomolar range. Stx-1 reduced NO production in non-stimulated GMVEC (5 nmol/l Stx-1 required) without inhibition of protein synthesis. In non-stimulated and TNFalpha-pretreated mesangial cells, NO production was reduced with a maximal reduction at 10 fmol/l shiga toxin. The cellular iNOS antigen content in mesangial cells was reduced in a concentration-dependent way (10 fmol/l-100 pmol/l), while partial inhibition of protein synthesis required 10 nmol/l Stx-1 in these cells. Our in vitro data suggest that Stx may reduce NO synthesis during the course of HUS development, contributing to the aggravation of the thrombotic microangiopathy and renal failure as observed in HUS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944213     DOI: 10.1007/s00467-006-0232-1

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  30 in total

1.  Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function.

Authors:  S C Head; M A Karmali; C A Lingwood
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

Review 2.  Role of nitric oxide in the control of renin secretion.

Authors:  A Kurtz; C Wagner
Journal:  Am J Physiol       Date:  1998-12

Review 3.  The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.

Authors:  A M Lefer; D J Lefer
Journal:  Cardiovasc Res       Date:  1996-10       Impact factor: 10.787

Review 4.  Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin.

Authors:  K Sandvig; B van Deurs
Journal:  Physiol Rev       Date:  1996-10       Impact factor: 37.312

Review 5.  Hemolytic-uremic syndrome. Current concepts and management.

Authors:  J S Fong; J P de Chadarevian; B S Kaplan
Journal:  Pediatr Clin North Am       Date:  1982-08       Impact factor: 3.278

6.  Protective role of nitric oxide in a model of thrombotic microangiopathy in rats.

Authors:  Jing Shao; Toshio Miyata; Koei Yamada; Norio Hanafusa; Takehiko Wada; Katherine L Gordon; Reiko Inagi; Kiyoshi Kurokawa; Toshiro Fujita; Richard J Johnson; Masaomi Nangaku
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

Review 7.  Recent advances in the regulation of nitric oxide in the kidney.

Authors:  Marcela Herrera; Jeffrey L Garvin
Journal:  Hypertension       Date:  2005-03-07       Impact factor: 10.190

8.  Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.

Authors:  R De Caterina; P Libby; H B Peng; V J Thannickal; T B Rajavashisth; M A Gimbrone; W S Shin; J K Liao
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.

Authors:  N C van de Kar; L A Monnens; M A Karmali; V W van Hinsbergh
Journal:  Blood       Date:  1992-12-01       Impact factor: 22.113

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  8 in total

1.  Aldose reductase regulates TNF-α-induced inducible nitric oxide synthase expression in human mesangial cells.

Authors:  Jingjing Zhao; Tao Jiang; Hui Li; Yuejuan Zhang; Nong Zhang
Journal:  Mol Biol Rep       Date:  2011-06-03       Impact factor: 2.316

Review 2.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 3.  Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.

Authors:  Andreas Bauwens; Josefine Betz; Iris Meisen; Björn Kemper; Helge Karch; Johannes Müthing
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

4.  The MAP kinase-activated protein kinase 2 (MK2) contributes to the Shiga toxin-induced inflammatory response.

Authors:  Jose B Saenz; Jinmei Li; David B Haslam
Journal:  Cell Microbiol       Date:  2009-11-27       Impact factor: 3.715

5.  Role of nitric oxide in shiga toxin-2-induced premature delivery of dead fetuses in rats.

Authors:  Juliana Burdet; Elsa Zotta; Maximiliano Cella; Ana M Franchi; Cristina Ibarra
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

6.  Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease.

Authors:  Tom G Obrig
Journal:  Toxins (Basel)       Date:  2010-12-02       Impact factor: 4.546

7.  L-arginine/NO pathway is altered in children with haemolytic-uraemic syndrome (HUS).

Authors:  Nele Kirsten Kanzelmeyer; Lars Pape; Kristine Chobanyan-Jürgens; Dimitrios Tsikas; Hans Hartmann; Anne-Jule Fuchs; Bernhard Vaske; Anibh Martin Das; Marion Haubitz; Jens Jordan; Thomas Lücke
Journal:  Oxid Med Cell Longev       Date:  2014-03-17       Impact factor: 6.543

Review 8.  Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome.

Authors:  Johanna Detzner; Gottfried Pohlentz; Johannes Müthing
Journal:  Toxins (Basel)       Date:  2020-06-04       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.